FDA Greenlights Expanded Remote Patient Monitoring to Keep Patients Out of Coronavirus-Slammed Hospitals

FDA Greenlights Expanded Remote Patient Monitoring to Keep Patients Out of Coronavirus-Slammed Hospitals

Posted Aug 21, 2020 from
Community%20of%20Practice/Join/green?scale=1.5


On Friday, the FDA issued a policy to facilitate greater use of remote patient monitoring technologies to cut back on hospital visits and thereby minimize the risk of exposure to COVID-19 while also reducing the burden on providers during the current crisis.

The remote patient monitoring device guidance applies to non-invasive devices that can be connected to a wireless network through Bluetooth, Wi-Fi or cellular connection to transmit a patient’s measurements directly to their healthcare provider or other monitoring entity. Some of the devices have the potential to apply algorithms to turn a patient’s physiological data into an index or alarm that may aid in diagnosing or assessing the severity of a condition.​

Continue reading at

Did you find this useful? Like


Next Article

  • FDA Greenlights Expanded Remote Patient Monitoring to Keep Patients Out of Coronavirus-Slammed Hospitals

    mHealth Devices are Changing Chronic Care Management Standards

    New research suggests that mHealth is changing the way physicians treat patients with chronic conditions. Telehealth and telemedicine advocates say a digital therapeutic platform for chronic care – …

    Posted Aug 21, 2020